Description General description An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Rufinamide is marketed as Banzel® in the US and Inovelon® in the EU. Application An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Legal Information CERILLIANT is a registered trademark of Cerilliant Corporation Snap-N-Shoot is a registered trademark of Cerilliant Corporation Snap-N-Spike is a registered trademark of Cerilliant Corporation